Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Inflammatory Breast Neoplasms 1

Interventions

Cyclophosphamide 10Radiotherapy 6Epirubicin 6Paclitaxel 5Docetaxel 5Trastuzumab 4Fluorouracil 4Doxorubicin 4Tamoxifen 3Neoadjuvant Therapy 3pertuzumab 2Surgical Procedures, Operative 2Filgrastim 2ferric carboxymaltose 1Thiotepa 1Taxes 1Razoxane 1Radiation 1Prochlorperazine 1Peripheral Blood Stem Cell Transplantation 1Palonosetron 1Microarray Analysis 1Methotrexate 1Injections, Subcutaneous 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Granisetron 1Dexrazoxane 1Dexamethasone 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Inflammatory Breast Neoplasms × CMF regimen × Clear all
NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡